|
|
Volumn 292, Issue 5515, 2001, Pages
|
|
HIV/AIDS treatment for millions
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
GENERIC DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
COMBINATION CHEMOTHERAPY;
DRUG COST;
HEALTH CARE ACCESS;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
VIRUS RESISTANCE;
AFRICA;
ARTICLE;
DEVELOPED COUNTRY;
DEVELOPING COUNTRY;
DRUG COMBINATION;
DRUG INDUSTRY;
ECONOMICS;
GOVERNMENT;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
PATENT;
UNITED NATIONS;
HUMAN IMMUNODEFICIENCY VIRUS;
HEALTH CARE AND PUBLIC HEALTH;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AFRICA;
ANTI-HIV AGENTS;
DEVELOPED COUNTRIES;
DEVELOPING COUNTRIES;
DRUG COSTS;
DRUG INDUSTRY;
DRUG THERAPY, COMBINATION;
DRUGS, GENERIC;
GOVERNMENT;
HIV INFECTIONS;
HUMANS;
INSURANCE, HEALTH;
PATENTS;
UNITED NATIONS;
|
|
EID: 0035853543
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1057504 Document Type: Short Survey |
|
Times cited : (29)
|
|
References (12)
|
